Inhibrx Biosciences (INBX) Assets (2023 - 2025)
Historic Assets for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $177.5 million.
- Inhibrx Biosciences' Assets fell 2026.0% to $177.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $177.5 million, marking a year-over-year decrease of 2026.0%. This contributed to the annual value of $180.8 million for FY2024, which is 4128.9% down from last year.
- Latest data reveals that Inhibrx Biosciences reported Assets of $177.5 million as of Q3 2025, which was down 2026.0% from $212.1 million recorded in Q2 2025.
- Over the past 5 years, Inhibrx Biosciences' Assets peaked at $307.9 million during Q4 2023, and registered a low of $177.5 million during Q3 2025.
- Moreover, its 3-year median value for Assets was $222.6 million (2024), whereas its average is $228.8 million.
- As far as peak fluctuations go, Inhibrx Biosciences' Assets tumbled by 4128.9% in 2024, and later crashed by 1791.67% in 2025.
- Over the past 3 years, Inhibrx Biosciences' Assets (Quarter) stood at $307.9 million in 2023, then tumbled by 41.29% to $180.8 million in 2024, then fell by 1.82% to $177.5 million in 2025.
- Its Assets stands at $177.5 million for Q3 2025, versus $212.1 million for Q2 2025 and $242.6 million for Q1 2025.